Results

Total Results: 9,447 records

Showing results for "cancer".
Users also searched for: colon cancer screening

261. Medical Care for Adults with Down Syndrome (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
     July 09, 2024 - cancersb Solid tumor cancers, including breast, prostate, testicular, cervical, and colon cancer. … Low risk of solid tumors in persons with Down syndrome. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or (hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?

262. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
     May 01, 2010 - Layout 1 Background Head and neck cancers, specifically those arising in the oral cavity, larynx, … sinuses/nasal cavity, salivary glands, and occult primaries, account for approximately 3 to 5 percent of cancers … The main challenge in radiation therapy for cancer is to attain the highest probability of tumor control … Comparative Effectiveness Review Number 20 2 tumors for more than 50 years, it has been used mostly … short compared to some common cancers, such as breast or colon cancer.

263. Chronic Condition Indicator (CCI) for ICD-9-CM
     hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp
     July 01, 2025 - Examples of chronic conditions include conditions such as malignancies, diabetes, most forms of mental … All cancers are considered chronic except basal cell carcinomas (173.0-173.9). … All benign neoplasms are considered non-chronic except benign neoplasms of the brain, cranial nerves, … Neoplasms of uncertain behavior are considered non-chronic except neurofibromatosis. … indicator is divided into the following categories: 1 = Infectious and parasitic disease 2 = Neoplasms

264. Screening for Bladder Cancer: Clinical Summary of U.S. Preventive Services Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/p8huvc8UM4WfAnrNAzYnXS
     Screening for Bladder Cancer: Clinical Summary of U.S. … is transurethral resection of the bladder tumor, which may be combined with adjuvant radiation therapy … There is inadequate evidence on harms of screening for bladder cancer. … the following: Potential preventable burden: early detection of tumors with malignant potential could … have an important impact on the mortality rate of bladder cancer.

265. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
     May 27, 2010 - treatment of prostate cancer, in addition to brain tumors, including those in children.” … a very large number of patients with similar tumors are randomized. … We have corrected the impression that xerostomia is common in patients with advanced cancers. … a very large number of patients with similar tumors are randomized. … We have corrected the impression that xerostomia is common in patients with advanced cancers.

266. Screening for Prostate Cancer: Clinical Summary of USPSTF Recommendation (2012) (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JosR5xCYBoK6K9BTbsaQD3
     Screening for Prostate Cancer: Clinical Summary of USPSTF Recommendation (2012) SCREENING FOR PROSTATE … CANCER CLINICAL SUMMARY OF U.S. … a tumor that either will not progress or will progress so slowly that it would have remained asymptomatic … Because of the current inability to reliably distinguish tumors that will remain indolent from those … The benefits of PSA-based screening for prostate cancer do not outweigh the harms.

267. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening-adults
     December 21, 2023 - or usual care on short- or long-term prostate cancer mortality, incidence of metastatic prostate cancer … of treatment vary in populations defined by age, race, ethnicity, family history, or Gleason grade/tumor … Do the harms vary in populations defined by age, race, ethnicity, family history, or Gleason grade/tumor … 1 , 2 have primarily detected early-stage cancer (90% to 96% of cancers detected). … screening and diagnostic workup; adding PSA density as a PSA-based screening approach; adding Gleason grade/tumor

268. CAHPS Cancer Care Survey: Radiation Therapy (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/rad-eng-cancer-551a.pdf
     October 07, 2016 - CAHPS Cancer Care Survey: Radiation Therapy CAHPS® Cancer Care Survey Version: Radiation Therapy … and shrink tumors. … How long have you been treated at this cancer center for cancer? … When was the last time you received radiation therapy for cancer from this cancer center? … cancer care experience possible Clerks and Receptionists at This Cancer Center 43.

269. Archived: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-2004
     May 04, 2004 - cohort studies using transvaginal ultrasound screening reported that 59 percent to 65 percent of ovarian cancers … were diagnosed in Stage I. 10 , 11 However, there is no evidence that detecting earlier-stage tumors … earlier treatment leads to a 40 percent mortality reduction) would yield a maximum of 4 additional cancers … American Cancer Society. Cancer Facts & Figures 2003 . … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

270. Future Research Needs Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - and the most aggressive breast cancers. … Population- based estimates of the relation between breast cancer risk, tumor subtype, and family history … Reactivation of Tumor Suppressor Genes in Breast Cancer by Dietary Supplements As. 2009. 178. 5F32AT004876 … Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature … /ep, et 10531 8 4 and 7 1164 9 exp breast neoplasms/pc, eh 7858 10 exp breast neoplasms/ge 18582

271. Final Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medication-use-reduce-risk
     March 21, 2024 - Share to Email Print in progress Final Research Plan Breast Cancer … What is the effectiveness of risk-reducing medications on primary breast cancer, breast cancer mortality … What are the harms of medications used to reduce primary breast cancer risk? … (including tumor receptor status) and DCIS; breast cancer mortality; all-cause mortality; and global … disorders Genitourinary outcomes Thromboembolic events Cardiovascular events Risk of other cancers

272. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
     May 01, 2018 - treatment of screen-detected tumors. … We used the following keywords: prostate cancer/neoplasms, PSA, mass screening, model, microsimulation … by CISNET as “computer models that operate at the level of individuals or smaller entities such as tumors … on age, PSA, or stage/grade of tumor). … Prostate Cancer Group (SPCG-4) trial, which was not conducted in men with screen-detected cancers.

273. Draft Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breast-cancer-medication-use-reduce-risk
     December 28, 2023 - Share to Email Print in progress Draft Research Plan Breast Cancer … What is the effectiveness of risk-reducing medications on primary invasive breast cancer, breast cancer … What are the harms of medications used to reduce primary breast cancer risk? … (including tumor receptor status) and DCIS; breast cancer mortality; all-cause mortality; and quality … disorders Genitourinary outcomes Thromboembolic events Cardiovascular events Risk of other cancers

274. Medical Care for Adults with Down Syndrome (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
     February 05, 2025 - cancersb Solid tumor cancers, including breast, prostate, testicular, cervical, and colon cancer. … Low risk of solid tumors in persons with Down syndrome. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or (hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?

275. Statistical Brief #125
     hcup-us.ahrq.gov/reports/statbriefs/sb125.jsp
     February 01, 2012 - among men, breast cancers among women, and colorectal cancers among both men and women. … malignancies (i.e., metastatic cancer), and lung cancer. … cancer, secondary malignancies (i.e., metastatic cancers), and lung cancer (figure 1). … Stays for all other common cancers decreased. … malignancies 499,300 14.6% Cancer of bronchus, lung 389,200 11.3% Cancer of colon

276. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
     July 08, 2002 - Rationale: The USPSTF found fair evidence that tamoxifen and raloxifene may prevent some breast cancers … that the drug was associated with an approximately 50 percent reduction in the risk for developing new cancers … women enrolled in BCPT, the women in these trials were younger, had more estrogen-receptor-negative cancers … When effective, both raloxifene and tamoxifen were effective only against estrogen receptor-positive tumors … (0.8 cancers/1,000 women taking placebo vs 3.1 cancers/1,000 women taking tamoxifen for a median of

277. Archived: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-january-2016
     January 11, 2016 - Most of the additional cancer detected by these methods are invasive tumors rather than ductal carcinoma … Although adjunctive screening may detect more breast cancer, these cancers may fall into 1 of 3 categories … (that is, cancer with adverse histologic features, such as poorly differentiated tumors and triple-negative … , but the tumor does not go on to behave as expected based on its appearance. … the tumor stops progressing at an early invasive stage.

278. Screening for Bladder Cancer in Adults - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/C6gCSoknL3qd32EDovsUsh
     November 01, 2004 - screening would be small, at best, for the following reasons: there is fair evidence that many of the cancers … tests—such as microscopic urinalysis, urine dipstick, urine cytology, or such new tests as bladder tumor … antigen (BTA) or nuclear matrix protein (NMP22) immunoassay—can detect bladder cancers that are clinically … Screening for Bladder Cancer in Adults Recommendation Statement U.S. … • Smoking increases the risk for bladder cancer; about 50% of all cases of bladder cancer occur in

279. Archived: Final Modeling Report: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-report/breast-cancer-screening-2009
     November 15, 2009 - Some groups model breast cancer in stages, but 3 (models E, S, and W) use tumor size and tumor growth … Age, estrogen receptor status, and tumor size- or stage-specific treatment have independent effects on … Women with estrogen receptor-negative invasive tumors receive nonhormonal therapy only. … Slow-growing tumors are much more common than fast-growing tumors, and the ratio of slow- to fast-growing … The MISCAN-Fadia continuous tumor growth model for breast cancer.

280. Why do GDPs fail to recognise oral cancer? The argument for an oral cancer checklist. | PSNet
     psnet.ahrq.gov/issue/why-do-gdps-fail-recognise-oral-cancer-argument-oral-cancer-checklist
     March 13, 2024 - Commentary Why do GDPs fail to recognise oral cancer? … The argument for an oral cancer checklist. Citation Text: Dave B. … Why do GDPs fail to recognise oral cancer? The argument for an oral cancer checklist. … This commentary explores causes for delayed diagnoses of oral cancers in general dental care and recommends … Why do GDPs fail to recognise oral cancer? The argument for an oral cancer checklist.